Ototoxicity in Cystic Fibrosis Patients Receiving Intravenous Tobramycin for Acute Pulmonary Exacerbation
The implementation of an aminoglycoside induced ototoxicity algorithm for people with cystic fibrosis
Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin
d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models